Skip to content

Contactless Detection of Sleep Apnea

Validation of a Contactless Sensor for Sleep Apnea Diagnosis Against Polysomnography

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04670848
Enrollment
116
Registered
2020-12-17
Start date
2020-12-07
Completion date
2021-12-21
Last updated
2022-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea

Brief summary

In this study the inestigators aim to validate the performance of Sleepiz One+ for sleep apnea detection during routine diagnostic sleep studies. Patients who are prescribed polysomnography study will be asked to participate and undergo a simultaneous sleep recording with radar sensor-based device.

Interventions

DEVICESleepiz One+ vs. polysomnography

Simultaneous sleep recording with polysomnography and Sleepiz One+ device

Sponsors

Sleepiz AG
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \>18years * Ability and consent to undergo electrophysiological routine assessment * Patients suspected to suffer from sleep apnea or any other sleep related disorder

Exclusion criteria

* Previous enrollment into the current study, * Enrollment of the investigator, his/her family members and other dependent persons * Cardiac pacemaker or another implanted electrical device * Women who are pregnant or breastfeeding * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant

Design outcomes

Primary

MeasureTime frame
Binary classification of subjects based on their sleep apnea severity (AHI ≥= 15) made by Sleepiz One+, compared to PSG data manually scored by sleep technicians1 Night

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026